A new paediatric formulation of the Pfizer BioNTech COVID-19 vaccine has been approved for children aged 5 to 11 after meeting the required safety, quality and effectiveness standards.
This site uses cookies, we have also updated our privacy policy in line with GDPR regulations. More info